ClinicalTrials.gg
Drug

Tobramycin clinical trials

Also written TOBI.

studies test it
60
open now
3
in phase 3
21
first study started
1995

Counted the way a researcher would: Tobramycin with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Tobramycin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Tobramycin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
11 Jun 1975 · NEBCIN · NDA 050477 (FDA, Drugs@FDA)
European Union
20 Jul 2011 · Tobi Podhaler · EMEA/H/C/002155 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tobramycin
24
Tobramycin Inhalation Powder
6
Tobramycin inhalation solution
3
Tobramycin Inhalant Product
2

Brand

TOBI
3
Aktob
1
Nebcin
1

Studies by the year they started

60 studies that test it; most in 2009 (6)

Studies that test Tobramycin, by start year
YearStudies
19951
19981
20011
20042
20052
20064
20071
20084
20096
20104
20112
20122
20134
20144
20152
20162
20172
20184
20193
20201
20212
20223
20232
20261

By phase

A phase 1/2 study counts in both.

Phase 1
13
Phase 2
9
Phase 3
21
Phase 4
15
No phase
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 22 · Other 38

Novartis Pharmaceuticals (7) · Novartis (4) · Bausch & Lomb Incorporated (3) · Alcon Research (3) · Washington University School of Medicine (2) · McMaster University (2) · Veroia General Hospital (2) · University Medical Center Groningen (2)

Often tested with

Tested in the same studies.

Vancomycin (7) · Ceftazidime (4) · Loteprednol Etabonate (3) · Ciprofloxacin (2) · Dexamethasone (2) · Meropenem (2) · Gentamicins (1) · Ofloxacin (1)

Studies

Open first, then newest update. How each study uses Tobramycin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 60

See all 60 studies that test Tobramycin →

Given beside what is tested · 4 — Tobramycin is usual care or a partner of the new treatment
As the comparator · 10 — what is tested is compared with Tobramycin

Codes

What other systems call Tobramycin · ClinicalTrials.gg INT008332

  • MeSH (NLM) D014031TobramycinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) VZ8RRZ51VKTOBRAMYCINConfirmed FDA, NLM, Wikidata
  • RxNorm 10627Confirmed FDA, Wikidata
  • Wikidata Q1758380tobramycinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62082TobramycinOne source FDA
  • DrugBank DB00684One source Wikidata

Also registered as tobramycin sulfate (UNII HJT0RXD7JK · RxNorm 7276).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.